These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26934697)

  • 1. Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
    Crowther GJ; Hillesland HK; Keyloun KR; Reid MC; Lafuente-Monasterio MJ; Ghidelli-Disse S; Leonard SE; He P; Jones JC; Krahn MM; Mo JS; Dasari KS; Fox AM; Boesche M; El Bakkouri M; Rivas KL; Leroy D; Hui R; Drewes G; Maly DJ; Van Voorhis WC; Ojo KK
    PLoS One; 2016; 11(3):e0149996. PubMed ID: 26934697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.
    Green JL; Moon RW; Whalley D; Bowyer PW; Wallace C; Rochani A; Nageshan RK; Howell SA; Grainger M; Jones HM; Ansell KH; Chapman TM; Taylor DL; Osborne SA; Baker DA; Tatu U; Holder AA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1464-75. PubMed ID: 26711771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum protein kinase as a potential therapeutic target for antimalarial drugs development.
    Mahmud F; Lee PC; Abdul Wahab H; Mustaffa KMF; Leow CH; Azhar R; Lai NS
    Trop Biomed; 2020 Sep; 37(3):822-841. PubMed ID: 33612795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and antiparasitic properties of inhibitors of the Plasmodium falciparum calcium-dependent protein kinase PfCDPK1.
    Ansell KH; Jones HM; Whalley D; Hearn A; Taylor DL; Patin EC; Chapman TM; Osborne SA; Wallace C; Birchall K; Large J; Bouloc N; Smiljanic-Hurley E; Clough B; Moon RW; Green JL; Holder AA
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6032-43. PubMed ID: 25070106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence Applied to the Rapid Identification of New Antimalarial Candidates with Dual-Stage Activity.
    Lima MNN; Borba JVB; Cassiano GC; Mottin M; Mendonça SS; Silva AC; Tomaz KCP; Calit J; Bargieri DY; Costa FTM; Andrade CH
    ChemMedChem; 2021 Apr; 16(7):1093-1103. PubMed ID: 33247522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel anti-malarial from structurally diverse library of molecules, targeting plant-like CDPK1, a multistage growth regulator of P. falciparum.
    Jain R; Gupta S; Munde M; Pati S; Singh S
    Biochem J; 2020 May; 477(10):1951-1970. PubMed ID: 32401306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
    Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
    ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.
    Bansal A; Ojo KK; Mu J; Maly DJ; Van Voorhis WC; Miller LH
    mBio; 2016 Dec; 7(6):. PubMed ID: 27923926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Dual-Stage Malaria Inhibitors with New Targets.
    Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.
    Kern S; Agarwal S; Huber K; Gehring AP; Strödke B; Wirth CC; Brügl T; Abodo LO; Dandekar T; Doerig C; Fischer R; Tobin AB; Alam MM; Bracher F; Pradel G
    PLoS One; 2014; 9(9):e105732. PubMed ID: 25188378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico Screening and Evaluation of Plasmodium falciparum Protein Kinase 5 (PK5) Inhibitors.
    Eubanks AL; Perkins MM; Sylvester K; Ganley JG; Posfai D; Sanschargrin PC; Hong J; Sliz P; Derbyshire ER
    ChemMedChem; 2018 Dec; 13(23):2479-2483. PubMed ID: 30328274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box.
    Tiwari NK; Reynolds PJ; Calderón AI
    Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The motor complex of Plasmodium falciparum: phosphorylation by a calcium-dependent protein kinase.
    Green JL; Rees-Channer RR; Howell SA; Martin SR; Knuepfer E; Taylor HM; Grainger M; Holder AA
    J Biol Chem; 2008 Nov; 283(45):30980-9. PubMed ID: 18768477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.
    Gaji RY; Checkley L; Reese ML; Ferdig MT; Arrizabalaga G
    Antimicrob Agents Chemother; 2014 May; 58(5):2598-607. PubMed ID: 24550330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).
    Chapman TM; Osborne SA; Bouloc N; Large JM; Wallace C; Birchall K; Ansell KH; Jones HM; Taylor D; Clough B; Green JL; Holder AA
    Bioorg Med Chem Lett; 2013 May; 23(10):3064-9. PubMed ID: 23570789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation.
    Ojo KK; Eastman RT; Vidadala R; Zhang Z; Rivas KL; Choi R; Lutz JD; Reid MC; Fox AM; Hulverson MA; Kennedy M; Isoherranen N; Kim LM; Comess KM; Kempf DJ; Verlinde CL; Su XZ; Kappe SH; Maly DJ; Fan E; Van Voorhis WC
    J Infect Dis; 2014 Jan; 209(2):275-84. PubMed ID: 24123773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasion of hepatocytes by Plasmodium sporozoites requires cGMP-dependent protein kinase and calcium dependent protein kinase 4.
    Govindasamy K; Jebiwott S; Jaijyan DK; Davidow A; Ojo KK; Van Voorhis WC; Brochet M; Billker O; Bhanot P
    Mol Microbiol; 2016 Oct; 102(2):349-363. PubMed ID: 27425827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.